| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Revenue | $878.3M | +10.8% |
| Cost of Revenue | $485.0M | +9.7% |
| Gross Profit | $393.3M | +12.1% |
| R&D Expense | $5.3M | -10.2% |
| SG&A Expense | $212.1M | +10.7% |
| Operating Income | $181.2M | +13.9% |
| Pre-tax Income | $180.1M | +28.2% |
| Income Tax | $42.6M | +12.4% |
| Net Income | $136.7M |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $225.8M | +919.3% |
| Accounts Receivable | $155.7M | +9.1% |
| Inventory | $194.9M | +29.3% |
| Current Assets | $592.9M | +78.9% |
| Total Assets | $1.38B | +32.2% |
| Current Liabilities | $147.2M | +27.1% |
| Long-term Debt | $0 | -100.0% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $168.4M | +2.5% |
| Investing Cash Flow | -$102.2M | -124.9% |
| Financing Cash Flow | $138.0M | +221.0% |
| +34.4% |
| EPS (Basic) | $8.41 | +28.6% |
| EPS (Diluted) | $8.38 | +28.5% |
| Total Liabilities |
| $286.6M |
| -29.8% |
| Stockholders' Equity | $1.07B | +74.1% |